Creo Medical Limited
CREO.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £55,983 | £70,525 | £121,159 | £165,385 |
| - Cash | £20,500 | £8,700 | £9,800 | £3,000 |
| + Debt | £4,200 | £4,400 | £14,200 | £8,300 |
| Enterprise Value | £39,683 | £66,225 | £125,559 | £170,685 |
| Revenue | £2,200 | – | £15,200 | £15,100 |
| % Growth | – | – | 0.7% | – |
| Gross Profit | £1,000 | – | £7,200 | £7,800 |
| % Margin | 45.5% | – | 47.4% | 51.7% |
| EBITDA | -£9,500 | – | -£11,800 | -£9,300 |
| % Margin | -431.8% | – | -77.6% | -61.6% |
| Net Income | £16,900 | – | -£12,300 | -£10,100 |
| % Margin | 768.2% | – | -80.9% | -66.9% |
| EPS Diluted | 0.041 | – | -0.034 | -0.028 |
| % Growth | – | – | -21% | – |
| Operating Cash Flow | £15,300 | £0 | -£13,700 | -£6,400 |
| Capital Expenditures | £0 | £0 | -£500 | -£800 |
| Free Cash Flow | £15,300 | £0 | -£14,200 | -£7,200 |